Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Amyloid β A4 (CT, 1-42) monoclonal antibody (8G7)

ADI-905-804-100 100 µg 457.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-804-412

Product Details

Immunogen:Synthetic peptide corresponding to aa 1-42 of amyloid β A4.
UniProt ID:P05067
Species reactivity:Human
Crossreactivity:Does not cross react with β A4 (1-40).
Applications:ELISA, ICC, WB
Recommended Dilutions/Conditions:ELISA (0.05µg/ml)
Immunocytochemistry (0.1-1.0µg/ml)
Western Blot (1µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~4kDa by Western blot.
Purity Detail:Thiophilic adsorption and size exclusion chromatography purified.
Formulation:Lyophilized from 1ml of 2x PBS containing 0.09% sodium azide, PEG, and sucrose.
Reconstitution:Reconstitute with 1ml water (15 minutes at room temperature).
Use/Stability:Stable at -80°C up to 1 year, at 4°C up to 3 months.
Shipping:Blue Ice
Long Term Storage:-20°C
Scientific Background:The β-amyloid peptide (β A4), proteolytically released from the amyloid precursor protein (APP), provides the principal component of senile plaques in Alzheimer's disease. Cleavage of APP by α-secretase or alternatively by β-secretase leads to generation and extracellular release of soluble APP peptides, S-APP-α and S-APP-β, respectively, and the retention of corresponding membrane-anchored C-terminal fragments, C83 and C99. Subsequent processing of C83 by γ-secretase yields P3 peptides. This is the major secretory pathway and is nonamyloidogenic. Alternatively, presenilin/ nicastrin-mediated γ-secretase processing of C99 releases the amyloid β proteins, amyloid-β 40 (Aβ40) and amyloid-β 42 (Aβ42), major components of amyloid plaques, and the cytotoxic C-terminal fragments, γ-CTF(50), γ-CTF(57) and γ-CTF(59).
Technical Info/Product Notes:Application Note:
Analysis of the Effect of Aggregated β-Amyloid on Cellular Signaling Pathways Critical for Memory in Alzheimer’s disease
Regulatory Status:RUO - Research Use Only
Amyloid β A4 (CT, 1-42) monoclonal antibody (8G7) Western blot
Western blot analysis of (1) β A4 (1-40), (2) β A4 (1-42), and (3) β A4 (1-43), probed with 2µg/ml of Amyloid β A4 (42) mAb (8G7).
Please mouse over
Amyloid β A4 (CT, 1-42) monoclonal antibody (8G7) Western blot

Related Products

Goat anti-mouse IgG F(ab')2, polyclonal antibody (HRP conjugate) 

ELISA, IHC, WB | Print as PDF
ADI-SAB-100-J 1 ml 150.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
Amyloid beta
By biological activity:
Amyloid beta Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Related Literature

Download as PDF

All new literature pieces